相关实验视频
Updated: Jan 29, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.4K
整酶抑制剂对新分化脂肪细胞的可逆效应
Richard Taylor Pickering1,2, Archana Asundi1,2, Alex Olson1
1Chobanian and Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Viruses
|January 28, 2026
概括
多卢特格拉维尔 (DTG) 可能会导致人体脂肪细胞的不良代谢变化,影响氨酸和瘦素分泌和能量产生. 这些影响在转换为达鲁纳维尔 (DRV) 时是可逆的.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 在现实研究中,体重增加与整合酶链转移抑制剂 (INSTIs) 有关,但因果关系尚不清楚.
- 多卢特格拉维尔 (DTG) 是一种常用于HIV治疗的INSTI.
- 研究DTG对人类脂肪细胞的直接影响对于了解潜在的代谢副作用至关重要.
研究的目的:
- 检查多卢特格拉维尔 (DTG) 对人类脂肪干细胞 (ASC) 和分化脂肪细胞的体外影响.
- 为了评估DTG诱导的变化的可逆性,通过切换到Darunavir (DRV),一种蛋白酶抑制剂.
- 阐明DTG对脂肪生成,脂肪分泌和细胞代谢的影响.
主要方法:
- 人类ASC和脂肪细胞被培养并暴露在DTG或DRV中.
- 细胞被评估为脂产生的结果 (三糖含量,基因表达,脂素分泌).
- 测量了新陈代谢参数,包括乳酸生产,脂解和氧气消耗.
主要成果:
- 在脂肪细胞中,DTG抑制了阿迪波涅克丁和莱普丁的分泌,这种效应通过切换到DRV而逆转.
- 暴露于DTG会增加细胞内膜网膜应激标志物和乳酸盐生产,同时抑制ASC中的氧气消耗.
- 在脂肪细胞分化过程中,DTG可降低甘油三积累和皮蛋白分泌,而不会改变关键的基因表达.
结论:
- 暴露于DTG会诱导人类脂肪细胞的功能变化,与不良的代谢表型相一致.
- 这些DTG诱导对脂肪细胞功能的影响在切换到DRV时是可逆的.
- 这些发现表明,潜在的细胞机制将INSTI使用与代谢变化联系在一起,突显了可逆性的重要性.
相关概念视频
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Reversible and Irreversible Processes
5.8K
The thermodynamic processes can be classified into reversible and irreversible processes. The processes that can be restored to their initial state are called reversible processes. It is only possible if the process is in quasi-static equilibrium, i.e., it takes place in infinitesimally small steps, and the system remains at equilibrium However, these are ideal processes and do not occur naturally. An ideal system undergoing a reversible process is always in thermodynamic equilibrium within...
5.8K
Diode: Reverse bias
1.9K
A diode is reverse-biased when the positive terminal of an external voltage source is connected to the n-type material and the negative terminal to the p-type material. This configuration opposes the natural direction of current flow through the diode, effectively increasing the width of the depletion region and the barrier potential. The reverse bias condition produces a minimal leakage current, primarily due to minority charge carriers. This leakage becomes significant when the reverse...
1.9K
Buffer Effectiveness
55.1K
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
The buffer capacity is the amount of acid or base that can be added to a given volume...
55.1K
Framing Effects
7.9K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.9K
Dipeptidyl Peptidase 4 Inhibitors
644
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
644

